Skip to Main Content

Paper Details

Impact of naloxone education for patients receiving buprenorphine-containing prescriptions indicated for opioid use disorder at an independent community pharmacy.
J Am Pharm Assoc (2003)
2
2020

Datasets

Release 1.2